Current and Future Treatment Options for Advanced Melanoma
Webcast
OVERVIEW
Current and Future Treatment Options for Advanced Melanoma is organized by Cleveland Clinic Center for Continuing Education and would be held during Feb 25, 2017 - Feb 25, 2018.
The target audience for this medical event for health care practitioners including medical oncologists, surgical oncologists, dermatologists, pathologists, and other health care professionals who manage patients with melanoma. This CME Conference has been approved with a maximum of 1.25 AMA PRA Category 1 Credits.
This webcast focuses on current progress in the treatment of patients with advanced melanoma. The multidisciplinary faculty present various aspects of the case, including radiolologic imaging, pathologic findings, mutation testing, risk assessment and treatment. Suggested treatment options are based on best practices, current treatment guidelines, and emerging clinical trial data on treatment of localized and metastatic disease. Choice of targeted agents, predictive markers, and use of immunotherapy for unresectable disease are also presented.
Conference Objectives are :
• Discuss indications for and potential benefits for surgery for patients with locoregional melanoma or metastatic disease, and following neoadjuvant therapy.
• Identify those patients who could benefit from radiotherapy, and which type of radiotherapy is best suited for a given patient.
• Summarize results from trials using targeted agents for advanced melanoma, such as small-molecule tyrosine kinase inhibitors.
• Differentiate between various immunotherapies for advanced melanoma in terms of mechanism of action, and cite efficacy results from key clinical trials.
Additional details will be posted as soon as they are available.
The target audience for this medical event for health care practitioners including medical oncologists, surgical oncologists, dermatologists, pathologists, and other health care professionals who manage patients with melanoma. This CME Conference has been approved with a maximum of 1.25 AMA PRA Category 1 Credits.
This webcast focuses on current progress in the treatment of patients with advanced melanoma. The multidisciplinary faculty present various aspects of the case, including radiolologic imaging, pathologic findings, mutation testing, risk assessment and treatment. Suggested treatment options are based on best practices, current treatment guidelines, and emerging clinical trial data on treatment of localized and metastatic disease. Choice of targeted agents, predictive markers, and use of immunotherapy for unresectable disease are also presented.
Conference Objectives are :
• Discuss indications for and potential benefits for surgery for patients with locoregional melanoma or metastatic disease, and following neoadjuvant therapy.
• Identify those patients who could benefit from radiotherapy, and which type of radiotherapy is best suited for a given patient.
• Summarize results from trials using targeted agents for advanced melanoma, such as small-molecule tyrosine kinase inhibitors.
• Differentiate between various immunotherapies for advanced melanoma in terms of mechanism of action, and cite efficacy results from key clinical trials.
Additional details will be posted as soon as they are available.
SPECIALITIES
OncologyDermatologyRELATED ONLINE COURSES
Quick Links